Hepatitis C virus inhibitors

The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Saved in:
Bibliographic Details
Main Authors NGUYEN, VAN N, YANG, ZHONG, ST. LAURENT, DENIS R, BENDER, JOHN A, BELEMA, MAKONEN, MEANWELL, NICHOLAS A, WANG, GAN, XU, NINGNING, LOPEZ, OMAR D, CHEN, QI, HEWAWASAM, PIYASENA, ROMINE, JEFFREY LEE, EASTER, JOHN A, SU, BAO-NING, SMITH, MICHAEL J
Format Patent
LanguageEnglish
Published 14.04.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Bibliography:Application Number: AU20100332034